Regulatory Considerations for Pharmaceutical Product Lifecycle Management
As a pharmaceutical product makes its way through the lifecycle, there are often Food and Drug Administration (FDA) guidelines organizations
As a pharmaceutical product makes its way through the lifecycle, there are often Food and Drug Administration (FDA) guidelines organizations
Cannabis use has become widespread. As such, we are seeing an uptick in research examining the therapeutic effects of cannabis
Advarra experts Sharon Ayd and Leslie Paul answer questions from their webinar, The IND Journey Phase I – Navigating Success.
Short form consents provide a crucial bridge for unexpected non-English speaking participants, ensuring informed consent remains accessible when translations aren’t readily available.
Efficient document systems like eTMF and eISF enhance compliance and streamline document management, helping sites and sponsors ensure secure, organized trial records.
Individuals invest a great deal to participate in clinical research, undertaking risks and burdens, while giving of their time and
As a drug successfully makes it through the development process, sponsors will inevitably need to submit a new drug application
Establishing a compliant pharmacovigilance (PV) function from scratch is often an overwhelming exercise for emerging biotech organizations, typically competing with
From protocol design to site training, optimizing study startup requires meticulous planning and collaboration to ensure timely trial activation.
Pre-screening subjects is common practice at most sites. In this article, learn some best practices and how technology can play an important role.
Like every institutional review board (IRB) – commercial or local – Advarra is subject to inspections from time to time.
Advarra expert Steffen Engel answers questions from the recent webinar, Stepwise Implementation of a Clinical Quality Management System. Q: How